openPR Logo
Press release

IonGate at the SBS Symposium Europe in Dresden

06-09-2008 12:33 PM CET | Science & Education

Press release from: IonGate Biosciences GmbH

/ PR Agency: Dr. Holger Bengs Biotech Consulting
SURFE2R Workstation 500

SURFE2R Workstation 500

Frankfurt/Main (Germany), 6th June 2008. IonGate Biosciences GmbH will present relevant application fields for the proprietary SURFE2R Technology (SURFace Electrogenic Event Reader) at the SBS Symposium “Label Free Technologies in Drug Discovery” in Dresden, Germany. The meeting is being held at the international congress center on June 10 – 11.

Dr. Henning Vollert will explain the advantages of the cell- and label-free technology in comparison to the more conventional patch clamp experiments in his presentation “Cell-free Electrophysiology – a Label-Free, High-Quality Readout Technology for Transporter Drug Discovery” on June 10. Dr. Vollert, a researcher at the University of Kiel, investigates pharmaceutically important transport proteins and their response to specific inhibitors.

At booth #25 IonGate will demonstrate the quality of the technology with a fully functional SURFE2R Workstation 500, a versatile platform for research on transport proteins, as it is currently found in many laboratories around the world.

Wolfgang Lerch
Managing Director
IonGate Biosciences GmbH
Industriepark Hoechst / Building D528
65926 Frankfurt/Main
Germany
phone +49.69.305.85 400
fax +49.69.305.85 444
email info@iongate.net

Wolfgang Lerch
President
IonGate Biosciences Inc.
25 Bradley Drive
Westbrook, Maine 04092-2013
U.S.A.
phone: +1.207.591.6376
fax: +1.207.591.6377
email info@iongate.net

Media inquiries
Dr. Holger Bengs
Biotech Consulting
phone +49.69.619.94 273
fax +49.69.619.94 249
email info@holgerbengs.de

About IonGate Biosciences GmbH

IonGate Biosciences GmbH develops, produces and markets innovative screening technologies to investigate transporters and is the worldwide leading company in this area.

Transporters are essential for the metabolic functions of the cell, information processing in the entire organism, and also play a fundamental role in the health of humans. Due to their difficult experimental accessibility transporters are underrepresented in current drug screening processes to date. For the first time, IonGate’s SURFE2R One and SURFE2R Workstation 500 provide highly precise functional screening of transporters in higher-throughput and thus positions itself as a leading partner for the pharmaceutical industry. With its SURFE2R Workstation 500 IonGate has created a technological basis for an automated and robust analytical technique. The company provides total system solutions, encompassing disposables and reagents, as well as individual consulting services which include the design of customized applications.

IonGate Biosciences GmbH is a venture capital financed biotechnology company located in Frankfurt/Main, Germany and Portland / Maine, USA. In addition to the main financier and leading partner Heidelberg Innovation the KfW holds a stake in IonGate. The company was established in 2000 and currently employs more than 30 staff members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IonGate at the SBS Symposium Europe in Dresden here

News-ID: 46462 • Views:

More Releases from IonGate Biosciences GmbH

IonGate honored for its SURFE2R Technology as “Landmark in the Land of Ideas 2008”
IonGate honored for its SURFE2R Technology as “Landmark in the Land of Ideas 2 …
Frankfurt/Main (Germany), November 18, 2008. IonGate Biosciences GmbH celebrated its election as “Landmark in the Land of Ideas“ by the initiative “Germany – Land of Ideas”. IonGate’s patented SURFE2R Technology (SURFace Electrogenic Event Reader) won the jury’s acclaim in the nationwide contest “365 Landmarks in the Land of Ideas”. SURFE2R Technology enables scientists to detect extremely small electric currents in cell membranes. Thus, it becomes possible to analyze the otherwise
IonGate boosts marketing and sales efforts in the US with new funding
Frankfurt/Main (Germany), 17th September 2008. IonGate Biosciences GmbH announces the closing of a new round of funding amounting to EUR 1 million. The capital contribution comes in as the new investor Hessen Kapital I GmbH joins in a silent partnership with IonGate and it will be used for further expansion of the US business as well as for the increase of the global commercialization of SURFE2R Technology (SURFace Electrogenic Event
IonGate increases throughput for transporter-based drug discovery with new SURFE …
Frankfurt/Main (Germany), 28th July 2008. IonGate Biosciences GmbH is pleased to announce the market launch of the innovative SURFE2R Workstation 5000. This fully integrated screening center is the new flagship model of IonGate’s SURFE2R product family, paving new ways in industrial automation of transporter screening for the pharmaceutical industry. With SURFE2R Workstation 5000, IonGate presents the latest automated system for direct functional measurement of the important new target class of transport
ARTEL and IonGate Join Forces to Advance Drug Discovery Research in North Americ …
Westbrook, ME (USA), Frankfurt / Main (Germany), 24th June, 2008. ARTEL and IonGate Biosciences announced their strategic partnership to support the growing application of IonGate’s drug discovery technology. The German biotechnology company will leverage ARTEL’s local infrastructure, customer relationships and market knowledge to increase the exposure and use of its discovery systems and assay development services in North America. The partnership will focus on IonGate’s SURFE2R Technology, which enables more

All 5 Releases


More Releases for SURFE2R

Nanion Acquires the SURFE2R Technology for Transporter Protein Analysis
Nanion acquires the well-established SURFE2R technology, allowing state-of-the-art measurements of transporter protein activity and function. The SURFE2R technology is an excellent enhancement to Nanion’s existing products which until now covered ion channels and nanopores. Nanion Technologies is one of the leading providers of high quality automated patch clamp systems. Nanion’s efficient and versatile products drastically improve the data output in patch clamp-based ion channel screening, safety testing and scientific research. Since
IonGate honored for its SURFE2R Technology as “Landmark in the Land of Ideas 2 …
Frankfurt/Main (Germany), November 18, 2008. IonGate Biosciences GmbH celebrated its election as “Landmark in the Land of Ideas“ by the initiative “Germany – Land of Ideas”. IonGate’s patented SURFE2R Technology (SURFace Electrogenic Event Reader) won the jury’s acclaim in the nationwide contest “365 Landmarks in the Land of Ideas”. SURFE2R Technology enables scientists to detect extremely small electric currents in cell membranes. Thus, it becomes possible to analyze the otherwise
IonGate increases throughput for transporter-based drug discovery with new SURFE …
Frankfurt/Main (Germany), 28th July 2008. IonGate Biosciences GmbH is pleased to announce the market launch of the innovative SURFE2R Workstation 5000. This fully integrated screening center is the new flagship model of IonGate’s SURFE2R product family, paving new ways in industrial automation of transporter screening for the pharmaceutical industry. With SURFE2R Workstation 5000, IonGate presents the latest automated system for direct functional measurement of the important new target class of transport
IonGate hosts workshop and presents new SURFE2R prototype at SBS 2008
Frankfurt/Main (Germany), March 31, 2008. IonGate Biosciences GmbH will present its SURFE2R Technology for label-free and automatic measurement of transport proteins in a workshop at the SBS 2008, 14th Annual Conference & Exhibition of the Society of Biomolecular Sciences. The meeting takes place in St. Louis, Missouri, USA, on April 6 – 10, 2008. Additionally IonGate will give an exclusive preview of the prototype for the new SURFE2R Workstation 5000. Immediately
IonGate starts commercialization of SURFE2R in Asia
Frankfurt/Main, Germany, March 12, 2008. IonGate Biosciences is expanding its operations to market the SURFE2R (SURFace Electrogenic Event Reader) Technology to the Japanese market. BRC - Bio Research Center Co. Ltd Nagoya, Japan and IonGate jointly introduce the proprietary technique to automatically screen transport proteins in high throughput at meetings in Japan, thus making the technology accessible to the Asian market. BRC is an established partner able to supply Japan’s researchers
IonGate presents SURFE2R Technology and relevant fields of application at Biophy …
Frankfurt/Main (Germany), January 28, 2008. IonGate Biosciences GmbH will present its SURFE2R Technology for label-free and automatic measurement of transport proteins at the 52nd Annual Meeting and 16th International Biophysics Congress. The joint meeting of the American Biophysical Society takes place in Long Beach, California, USA, on February 2 – 6, 2008. Scientists from industry, universities and private academic institutes use this opportunity to present results of their latest research